Conflict of interest and institutional review boards
Cho, M.K.; Billings, P.
Journal of Investigative Medicine the Official Publication of the American Federation for Clinical Research 45(4): 154-159
1997
ISSN/ISBN: 1081-5589
PMID: 9154295
Accession: 045619980
PDF emailed within 1 workday: $29.90
Related References
Weinfurt, K.P.; Friedman, Jëlle.Y.; Dinan, M.A.; Allsbrook, J.S.; Hall, M.A.; Dhillon, J.K.; Sugarman, J. 2006: Disclosing conflicts of interest in clinical research: views of institutional review boards, conflict of interest committees, and investigators Journal of Law Medicine and Ethics: a Journal of the American Society of Law Medicine and Ethics 34(3): 581-91 481Maloney, D.M. 2001: Institutional review boards and financial conflict of interest Human Research Report 16(5): 1-2
Shamoo, A.E. 1999: Institutional review boards (IRBs) and conflict of interest Accountability in Research 7(2-4): 201-212
Maloney, D.M. 2001: Institutional review boards should not have primary conflict of interest duty Human Research Report 16(8): 1-2
Freedman, R.S.; McKinney, R. 2013: Is conflict of interest becoming a challenge for institution-based institutional review boards? Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 19(15): 4034-4039
Maloney, D.M. 2002: Institutional review boards and financial conflicts of interest Human Research Report 17(2): 1-2
Lemmens, T.; Freedman, B. 2000: Ethics review for sale? Conflict of interest and commercial research review boards Milbank Quarterly 78(4): 547-84 Iii-Iv
Trudo Lemmens; Benjamin Freedman 2000: Ethics Review for Sale? Conflict of Interest and Commercial Research Review Boards Milbank Quarterly 78(4): 547-584
Wise, J. 2015: Institutional review boards are getting better at dealing with conflicts of interest, survey shows Bmj 351: H3793
Kaur, S.; Balan, S. 2015: Towards a balanced approach to identifying conflicts of interest faced by institutional review boards Theoretical Medicine and Bioethics 36(5): 341-361
Pivovarova, E.; Klitzman, R.L.; Murray, A.; Stiles, D.F.; Appelbaum, P.S.; Lidz, C.W. 2019: How Single Institutional Review Boards Manage Their Own Conflicts of Interest: Findings From a National Interview Study Academic Medicine: Journal of the Association of American Medical Colleges 94(10): 1554-1560
Vogeli, C.; Koski, G.; Campbell, E.G. 2009: Policies and management of conflicts of interest within medical research institutional review boards: results of a national study Academic Medicine: Journal of the Association of American Medical Colleges 84(4): 488-494
Hasselmo, N. 2002: Individual and institutional conflict of interest: policy review by research universities in the United States Science and Engineering Ethics 8(3): 421-427
Ticse, R.; Villarreal, Víctor.; Díaz-Vélez, C. 2014: Conflict of interest disclosure and institutional review board on research published in SciELO Peru Revista Peruana de Medicina Experimental y Salud Publica 31(1): 169-180
Rowan-Legg, A.; Weijer, C.; Gao, J.; Fernandez, C. 2009: A comparison of journal instructions regarding institutional review board approval and conflict-of-interest disclosure between 1995 and 2005 Journal of Medical Ethics 35(1): 74-78
Klitzman, R. 2013: How good does the science have to be in proposals submitted to Institutional Review Boards? An interview study of Institutional Review Board personnel Clinical Trials 10(5): 761-766
Grady, C. 2019: Bioethics in the Oversight of Clinical Research: Institutional Review Boards and Data and Safety Monitoring Boards Kennedy Institute of Ethics Journal 29(1): 33-49
Rozovsky, L.E. 1974: Conflict of interest on hospital boards Dimensions in Health Service 51(2): 8-9
Valery, M. Gordon, J Sugarman and Nancy Kass 1998: Toward a More Comprehensive Approach to Protecting Human Subjects: The Interface of Data Safety Monitoring Boards and Institutional Review Boards in Randomized Clinical Trials Irb Ethics and Human Research 20(1): 1-5
Gordon, V.M.; Sugarman, J.; Kass, N. 1998: Toward a more comprehensive approach to protecting human subjects: the interface of data safety monitoring boards and institutional review boards in randomized clinical trials Irb 20(1): 1-5